Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 340 followers
Latest posts
Last updated about 14 hours ago
From executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industry
about 14 hours ago
When Charles River Laboratories CEO Birgit Girshick started her career as an...
ADA: Novo’s Lange says ‘jury still out’ on CagriSema amid tough retatrutide comparisons
about 16 hours ago
Even as industry watchers pit the two assets against one another, it’s...
GLP-1s may combat depression by multiplying a mood-boosting gut microbe
about 16 hours ago
Since GLP-1 drugs like Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide took...
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
about 17 hours ago
Bay Area biotech SonoThera is bubbling to a clinical boil after raising...
Ethyreal Bio manifests with $101M in pack of biotechs gunning for Amgen’s Tepezza
about 18 hours ago
Ethyreal Bio has exited stealth with $101 million, joining the queue of...
Novartis sticks 2nd deal with molecular glue biotech Orionis, this one worth up to $1.4B
about 19 hours ago
Novartis has stuck on a second deal with Orionis Biosciences, this time...
Cancer-focused Parabilis’ upsized $670M IPO breaks new for record for biotechs
about 22 hours ago
Parabilis Medicines’ IPO has lived up to the hype—securing $670 million for...
Sanofi halts phase 3 autoimmune trial early over insufficient efficacy as pipeline woes continue
about 23 hours ago
Sanofi has stopped a phase 3 autoimmune clinical trial early after an...
Fueled by M&A and partnerships, biotech is poised for continued growth: EY
1 day ago
Biotech’s effervescent activity has allowed it to overcome headwinds and sustain momentum...
Galmed acquires Colospan in $4.5M deal as it eyes $6B GI dx market
1 day ago
Galmed Pharmaceuticals acquired Colospan in a $4.5 million million deal as the...
Cancer biotech Parabilis ups IPO plans to potentially record-setting $637M
1 day ago
Mere months after obesity biotech Kailera Therapeutics netted the biggest initial public...
ADA: AZ’s oral GLP-1 shows ‘competitive efficacy’ in phase 2, setting stage for pivotal program
1 day ago
With a pair of phase 2 readouts, AstraZeneca is positioning itself to...